LEADER 04275nam 22005655 450 001 9910338043903321 005 20200630194810.0 010 $a3-319-76834-4 024 7 $a10.1007/978-3-319-76834-2 035 $a(CKB)4100000005248172 035 $a(DE-He213)978-3-319-76834-2 035 $a(MiAaPQ)EBC5451262 035 $a(PPN)25947326X 035 $a(EXLCZ)994100000005248172 100 $a20180710d2019 u| 0 101 0 $aeng 135 $aurnn|008mamaa 181 $ctxt$2rdacontent 182 $cc$2rdamedia 183 $acr$2rdacarrier 200 10$aHealth Innovation and Social Justice in Brazil /$fedited by Maurice Cassier, Marilena Correa 205 $a1st ed. 2019. 210 1$aCham :$cSpringer International Publishing :$cImprint: Palgrave Macmillan,$d2019. 215 $a1 online resource (XV, 281 p. 11 illus., 9 illus. in color.) 311 $a3-319-76833-6 327 $a1. General Introduction -- 2. Knowledge Generation and Laboratory Capacity Building in the Fight against HIV/AIDS in Brazil: Experiences on the Development of a Heat-Stable Formulation Comprising Ritonavir -- 3. Nationalizing Efavirenz: Compulsory Licence, Collective Invention and Neo-Developmentalism in Brazil -- 4. The Introduction of Nucleic Acid Tests (NAT) for Blood Screening in the Brazilian Public Healthcare System: Negotiating and Assembling Technologies for the Nationalization of ?Nat Brasileiro? (2005?2013) -- 5. The Innovation System for the Leishmaniasis Therapy in Brazil -- 6. A Consortium in Times of Crisis: Producing Brazilian Sofosbuvir? (2014?2017) -- 7. Health Rights and Intellectual Property Rights: Ministry of Health Prior Consent for Pharmaceutical Patents in Brazil -- 8. Polymorph Drug Patents and Their Public Health Impact -- 9. Treatment Activism and Intellectual Property of Drugs in Brazil -- 10. Regulating the Copy Drug Market in Brazil: Testing Generics and Similar Medicines (1999?2015). 330 $aThis book examines the construction of an innovation system in Brazil?s health industries over the past twenty years. The authors argue that the system has remained active despite the crisis that began in 2014. However, while this crisis has led to cuts in public spending on research and health, it has simultaneously tended to stimulate local production and invention aimed at reducing deficits in the trade in medicines and medical technologies. The contributors highlight a model combining the acquisition of new technologies with social justice and the right to health, and introduce new concepts of the ?nationalization? of technologies, innovation through copying and civil society regulation of industrial property and of the medicinal drug market. Maurice Cassier is Senior Researcher at the French National Center for Scientific Research. Marilena Correa is Senior Associate Professor at the Institute of Social Medicine-IMS, Brazil. . 606 $aEconomic development 606 $aSocial change 606 $aLatin America?Politics and government 606 $aDevelopment and Social Change$3https://scigraph.springernature.com/ontologies/product-market-codes/913030 606 $aLatin American Politics$3https://scigraph.springernature.com/ontologies/product-market-codes/911150 606 $aRegional Development$3https://scigraph.springernature.com/ontologies/product-market-codes/913050 606 $aDevelopment and Health$3https://scigraph.springernature.com/ontologies/product-market-codes/913060 606 $aDevelopment Theory$3https://scigraph.springernature.com/ontologies/product-market-codes/913010 615 0$aEconomic development. 615 0$aSocial change. 615 0$aLatin America?Politics and government. 615 14$aDevelopment and Social Change. 615 24$aLatin American Politics. 615 24$aRegional Development. 615 24$aDevelopment and Health. 615 24$aDevelopment Theory. 676 $a338.4761510981 702 $aCassier$b Maurice$4edt$4http://id.loc.gov/vocabulary/relators/edt 702 $aCorrea$b Marilena$4edt$4http://id.loc.gov/vocabulary/relators/edt 906 $aBOOK 912 $a9910338043903321 996 $aHealth Innovation and Social Justice in Brazil$92521414 997 $aUNINA